Axsome Therapeutics target price cut to $225 from $245
AXSM•Leerink Partners cut its target price for Axsome Therapeutics to $225 from $245.
Related News
Principal Financial Group target price cut to $105 from $106
PFG•
Stephens raises Oracle to overweight from equal weight, raises target price to $213 from $185
ORCL•
Tempus AI upgraded to hold from underperform; price target raised to $70 from $35
TEM•
Krystal Biotech: BofA Global Research cuts price objective to $390 from $400
KRYS•
New York Times business news - November 3
AAPL•